Urogen Pharma Ltd
(URGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 220,797 | 132,262 | 95,823 | 120,122 | 20,943 |
| Marketable Securities | 21,106 | 32,606 | 41,966 | 28,114 | 27,174 |
| Receivables | 17,415 | 14,158 | 15,443 | 12,847 | 15,505 |
| Inventories | 7,442 | 7,243 | 5,673 | 5,002 | 4,988 |
| TOTAL | $278,968 | $196,760 | $169,186 | $182,123 | $81,333 |
| Non-Current Assets | |||||
| PPE Net | 580 | 566 | 689 | 823 | 910 |
| Investments And Advances | 203 | 481 | 4,502 | 6,507 | 7,970 |
| Other Non-Current Assets | 2,098 | 2,767 | 3,934 | 4,180 | 5,148 |
| TOTAL | $2,881 | $3,814 | $9,125 | $11,510 | $14,028 |
| Total Assets | $281,849 | $200,574 | $178,311 | $193,633 | $95,361 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 23,754 | 18,158 | 16,538 | 14,083 | 16,403 |
| Accrued Expenses | 6,849 | 4,985 | 10,814 | 8,152 | 6,721 |
| Other current liabilities | 3,620 | 3,197 | 3,860 | 3,553 | 3,641 |
| TOTAL | $34,223 | $26,340 | $31,212 | $25,788 | $26,765 |
| Non-Current Liabilities | |||||
| Long Term Debt | 97,813 | 97,590 | 98,551 | 98,518 | 98,296 |
| Other Non-Current Liabilities | 119,499 | 116,778 | 113,760 | 111,320 | 108,734 |
| TOTAL | $217,312 | $214,368 | $212,311 | $209,838 | $207,030 |
| Total Liabilities | $251,535 | $240,708 | $243,523 | $235,626 | $233,795 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 42,114 | 36,130 | 34,122 | 30,866 | 30,283 |
| Common Shares | 112 | 99 | 89 | 84 | 64 |
| Retained earnings | -745,037 | -711,634 | -679,348 | -653,332 | -631,453 |
| Other shareholders' equity | -31 | -37 | 12 | -134 | -154 |
| TOTAL | $30,314 | $-40,134 | $-65,212 | $-41,993 | $-138,434 |
| Total Liabilities And Equity | $281,849 | $200,574 | $178,311 | $193,633 | $95,361 |